We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
SCLP.LSE

Price
8.25
Stock movement up
+0.10 (1.23%)
Company name
Scancell Hldgs Plc
Exchange
(LSE
,
Currency
GBX
)
Sector
Healthcare >
Biotechnology
Market cap
7.67B
Ent value
7.68B
Price/Sales
1454.98
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-13.69%
1 year return
-14.51%
3 year return
-21.80%
5 year return
9.88%
10 year return
-11.10%
Last updated: 2025-04-12

DIVIDENDS

SCLP.LSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales1454.98
Price to Book-
EV to Sales1457.31

FINANCIALS

Per share

Per share data
Current share count929.60M
EPS (TTM)-0.02
FCF per share (TTM)-0.02

Income statement

Income statement data
Revenue (TTM)5.27M
Gross profit (TTM)2.88M
Operating income (TTM)-30.19M
Net income (TTM)-17.80M
EPS (TTM)-0.02
EPS (1y forward)-1.51

Margins

Margins data
Gross margin (TTM)54.60%
Operating margin (TTM)-572.70%
Profit margin (TTM)-337.60%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash14.82M
Net receivables5.85M
Total current assets21.87M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment4.23M
Total assets23.58M
Accounts payable1.46M
Short/Current long term debt19.87M
Total current liabilities6.39M
Total liabilities27.08M
Shareholder's equity-3.50M
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-24.29M
Capital expenditures (TTM)380.00K
Free cash flow (TTM)-20.19M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-75.48%
Return on Invested Capital-111.95%
Cash Return on Invested Capital-127.01%

STOCK INFORMATION

Stock chart

Stock price data
Open8.15
Daily high8.50
Daily low8.11
Daily Volume57K
All-time high60.44
1y analyst estimate24.77
Beta0.45
EPS (TTM)-0.02
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Downside potential data
SCLP.LSES&P500
Current price drop from All-time high-86.35%-12.89%
Highest price drop-93.71%-56.47%
Date of highest drop9 May 20199 Mar 2009
Avg drop from high-66.26%-11.07%
Avg time to new high215 days12 days
Max time to new high3160 days1805 days
COMPANY DETAILS
SCLP.LSE (Scancell Hldgs Plc) company logo
Marketcap
7.67B
Marketcap category
Mid-cap
Description
Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease. Its product candidates include SCIB1, an ImmunoBody cancer vaccine that is in Phase II for the treatment of metastatic melanoma; and SCIB2/iSCIB2 vaccine, which is under evaluation for the treatment of patients with solid tumors, including non-small cell lung cancer. It also develops Modi-1, a citrullinated peptides vaccine that is in phase I/II clinical trials for the treatment of solid tumors including triple negative breast, melanoma, ovarian, lung, and pancreatic cancers; and Modi-2, which targets homocitrullinated cancer antigens. In addition, the company focuses to develop SCOV1 and SCOV2 COVIDITY, a DNA vaccine against the SARS-CoV-2 virus. Scancell Holdings plc was founded in 1997 and is based in Oxford, the United Kingdom.
Employees
61
Website
https://www.scancell.co.uk
Investor relations
-
SEC filings
SCLP.LSE SEC filings
CEO
Country
UK
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved